Trials / Conditions / Meningeal Chronic Myelogenous Leukemia

Meningeal Chronic Myelogenous Leukemia

7 registered clinical trials studyying Meningeal Chronic Myelogenous Leukemia.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic NCT01199562	City of Hope Medical Center	—
Completed	Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Canc NCT01053494	Wake Forest University Health Sciences	N/A
Completed	Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem NCT00489203	Fred Hutchinson Cancer Center	Phase 2
Terminated	Sunitinib in Treating Patients With Idiopathic Myelofibrosis NCT00387426	National Cancer Institute (NCI)	Phase 2
Completed	Dasatinib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Philadelphia Chromosome-Posi NCT00316953	National Cancer Institute (NCI)	Phase 1
Completed	Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction NCT00025415	National Cancer Institute (NCI)	Phase 1
Completed	Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenola NCT00112593	Fred Hutchinson Cancer Center	N/A